top of page
Home
Technology
Pipeline
Female Stress Urinary Incontinence
About Us
Open Positions
Investors & Media
Contact
More...
Use tab to navigate through the menu items.
ALL POSTS
NEWS
MEDIA
RESOURCES
AWARDS
PUBLICATIONS
Search
MUVON Therapeutics Clears Phase 2 Interim Milestone and Will Participate in the 2025 J.P. Morgan Healthcare Conference
MUVON clears phase 2 interim milestone and announces participation in 2025 J.P. Morgan Healthcare Conference
Jan 9, 2025
2 min read
MUVON featured in PharmaBoardroom Interview
MUVON CEO, Deana Mohr-Haralampieva, was recently featured in an exclusive interview with PharmaBoardroom
Nov 12, 2024
1 min read
MUVON Therapeutics announces appointments to its Advisory Board.
MUVON Therapeutics announces the appointment of Dorothea Ledergerber, PhD, and Christoph Herwig, PhD to its Advisory Board.
Oct 28, 2024
2 min read
INVEST IN OUR
INNOVATION
MORE INFORMATION
Invest in us to be part of a groundbreaking journey toward innovative, life-changing muscle regeneration therapies, addressing a massive global market with scalable solutions.
bottom of page
